These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 2644608)
21. Increased beta 2-microglobulin (B2M) is useful in the detection of post-transplant lymphoproliferative disease (PTLD). Sasaki TM; Pirsch JD; D'Alessandro AM; Knechtle SJ; Kalayoglu M; Hafez GR; Sollinger HW Clin Transplant; 1997 Feb; 11(1):29-33. PubMed ID: 9067691 [TBL] [Abstract][Full Text] [Related]
22. [Changes in serum and urine ceruloplasmin concentrations in type 2 diabetes]. Qin LX; Zeng X; Huang G Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):208-11. PubMed ID: 16145917 [TBL] [Abstract][Full Text] [Related]
23. Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia. Rodriguez J; Cortes J; Talpaz M; O'Brien S; Smith TL; Rios MB; Kantarjian H Clin Cancer Res; 2000 Jan; 6(1):147-52. PubMed ID: 10656443 [TBL] [Abstract][Full Text] [Related]
24. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy. Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929 [TBL] [Abstract][Full Text] [Related]
25. Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children. Herrero-Morín JD; Málaga S; Fernández N; Rey C; Diéguez MA; Solís G; Concha A; Medina A Crit Care; 2007; 11(3):R59. PubMed ID: 17519026 [TBL] [Abstract][Full Text] [Related]
26. [Usefulness of beta-2-microglobulin determination in the differential diagnosis of infections in the upper and lower parts of the urinary tract]. Pupek-Musialik D Wiad Lek; 1990 Mar 1-15; 43(5-6):183-7. PubMed ID: 2195774 [TBL] [Abstract][Full Text] [Related]
27. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients. Navarro JF; Mora C; Muros M; García J Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891 [TBL] [Abstract][Full Text] [Related]
28. [Regulation of natriuresis in diabetic nephropathy]. Późniak J Ann Acad Med Stetin; 2000; 46():241-52. PubMed ID: 11712308 [TBL] [Abstract][Full Text] [Related]
29. [Serum beta 2-microglobulin in multiple myeloma. II. Its significance in monitoring the disease]. Scudla V; Budíková M; Fischerová E; Raska I; Vavrdová V Vnitr Lek; 1991 May; 37(5):479-87. PubMed ID: 1842146 [TBL] [Abstract][Full Text] [Related]
30. The clinical use of serum beta-2-microglobulin and fractional beta-2-microglobulin excretion in IgA nephropathy. Lai KN; Lai FM; Vallance-Owen J Clin Nephrol; 1986 May; 25(5):260-5. PubMed ID: 3522000 [TBL] [Abstract][Full Text] [Related]
31. Exercise induced proteinuria as an early indicator of diabetic nephropathy. Agarwal RP; Thanvi I; Vachhani G; Kochar DK; Rastogi A J Assoc Physicians India; 1998 Sep; 46(9):772-4. PubMed ID: 11229244 [TBL] [Abstract][Full Text] [Related]
32. Enhanced activity of serum and urinary hyaluronidases in streptozotocin-induced diabetic Wistar and GK rats. Ikegami-Kawai M; Okuda R; Nemoto T; Inada N; Takahashi T Glycobiology; 2004 Jan; 14(1):65-72. PubMed ID: 14551218 [TBL] [Abstract][Full Text] [Related]
33. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?]. Peczyńska J; Urban M; Głowińska B; Florys B Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367 [TBL] [Abstract][Full Text] [Related]
34. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression. Popławska-Kita A; Mierzejewska-Iwanowska B; Szelachowska M; Siewko K; Nikołajuk A; Kinalska I; Górska M Diabetes Metab Res Rev; 2008; 24(4):310-7. PubMed ID: 18273859 [TBL] [Abstract][Full Text] [Related]
35. [Prognostic value of serum beta2-microglobulin in multiple myeloma]. Bettini R; Redaelli S; Maino C; Bertuol S; Costantini C; Lazzarini A; Brivio L; Gorini M Recenti Prog Med; 2005 Feb; 96(2):81-6. PubMed ID: 15844767 [TBL] [Abstract][Full Text] [Related]
36. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus. Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141 [TBL] [Abstract][Full Text] [Related]
38. Serum beta-2-microglobulin in the differential diagnosis of monoclonal gammopathies. Elias J; Dauth J; Senekal JC; van der Walt P; Joubert HF; Kühn F; Greenacre M S Afr Med J; 1991 Jun; 79(11):650-3. PubMed ID: 2047946 [TBL] [Abstract][Full Text] [Related]
39. [Relationship between the changes of beta2-microglobulin in blood and urine and kidney involvements in children with pneumonia]. Lin MX; Huang YH; Mai J; Weng CH; Yang YF Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):100-2. PubMed ID: 12857470 [TBL] [Abstract][Full Text] [Related]
40. Elevated levels of plasma and urine beta-thromboglobulin or thromboxane-B2 as markers of real platelet hyperactivation in diabetic nephropathy. Tóth L; Szénási P; Varsányi MN; Szilvási I; Lehoczky E; Kammerer L; Romics L Haemostasis; 1992; 22(6):334-9. PubMed ID: 1478544 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]